G140

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H533080

CAS#: N/A

Description: G140 is a Novel potent cGAS-specific inhibitor for repression of dsDNA-triggered interferon expression ( IC50 of 14 nM and 442 nM for h-cGAS and m-cGAS, respectively).

Chemical Structure

img
G140
CAS# N/A
Instruction

Theoretical Analysis

Hodoodo Cat#: H533080
Name: G140
CAS#: N/A
Chemical Formula: C17H16Cl2N4O2
Exact Mass: 378.07
Molecular Weight: 379.241
Elemental Analysis: C, 53.84; H, 4.25; Cl, 18.70; N, 14.77; O, 8.44

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: G140; G-140; G 140

IUPAC/Chemical Name: 1-(6,7-Dichloro-9-(1-methyl-1H-pyrazol-3-yl)-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)-2-hydroxyethan-1-one

InChi Key: NVPFAXHXXODQRO-UHFFFAOYSA-N

InChi Code: InChI=1S/C17H16Cl2N4O2/c1-22-4-2-13(21-22)9-6-11(18)16(19)17-15(9)10-7-23(14(25)8-24)5-3-12(10)20-17/h2,4,6,20,24H,3,5,7-8H2,1H3

SMILES Code: O=C(N(C1)CCC(N2)=C1C3=C2C(Cl)=C(Cl)C=C3C4=NN(C)C=C4)CO

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 379.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Rhee SY, Grant PM, Tzou PL, Barrow G, Harrigan PR, Ioannidis JPA, Shafer RW. A
systematic review of the genetic mechanisms of dolutegravir resistance. J
Antimicrob Chemother. 2019 Nov 1;74(11):3135-3149. doi: 10.1093/jac/dkz256.
PubMed PMID: 31280314; PubMed Central PMCID: PMC6798839.


2: Ferrari D, Spagnuolo V, Manca M, Bigoloni A, Muccini C, Banfi G, Locatelli M,
Castagna A. Increased dose of dolutegravir as a potential rescue therapy in
multi-experienced patients. Antivir Ther. 2019;24(1):69-72. doi: 10.3851/IMP3275.
PubMed PMID: 30353884.


3: Videlock EJ, Mahurkar-Joshi S, Hoffman JM, Iliopoulos D, Pothoulakis C, Mayer
EA, Chang L. Sigmoid colon mucosal gene expression supports alterations of
neuronal signaling in irritable bowel syndrome with constipation. Am J Physiol
Gastrointest Liver Physiol. 2018 Jul 1;315(1):G140-G157. doi:
10.1152/ajpgi.00288.2017. Epub 2018 Mar 22. PubMed PMID: 29565640; PubMed Central
PMCID: PMC6109711.


4: Azuma K, Umezu T, Imanishi S, Asano M, Yoshizawa S, Katagiri S, Ohyashiki K,
Ohyashiki JH. Genetic variations of bone marrow mesenchymal stromal cells derived
from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
Leuk Res. 2017 Nov;62:23-28. doi: 10.1016/j.leukres.2017.09.008. Epub 2017 Sep
21. PubMed PMID: 28964959.


5: Xiao L, Ding M, Zhang Y, Chordia M, Pan D, Shimer A, Shen F, Glover D, Jin L,
Li X. A Novel Modality for Functional Imaging in Acute Intervertebral Disk
Herniation via Tracking Leukocyte Infiltration. Mol Imaging Biol. 2017
Oct;19(5):703-713. doi: 10.1007/s11307-016-1038-6. PubMed PMID: 28050750; PubMed
Central PMCID: PMC5495619.


6: Soulié C, Assoumou L, Darty M, Rodriguez C, Donati F, Sayon S, Peytavin G,
Valantin MA, Caby F, Schneider L, Canestri A, Costagliola D, Katlama C, Calvez V,
Marcelin AG; ROCnRAL ANRS-157 Study Group. Virological factors associated with
outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial). J Antimicrob
Chemother. 2015 Dec;70(12):3339-44. doi: 10.1093/jac/dkv280. Epub 2015 Sep 22.
PubMed PMID: 26396157.


7: Zou J, Lee le T, Wang QY, Xie X, Lu S, Yau YH, Yuan Z, Geifman Shochat S, Kang
C, Lescar J, Shi PY. Mapping the Interactions between the NS4B and NS3 proteins
of dengue virus. J Virol. 2015 Apr;89(7):3471-83. doi: 10.1128/JVI.03454-14. Epub
2015 Jan 14. PubMed PMID: 25589636; PubMed Central PMCID: PMC4403433.


8: Koay LC, Rigby RJ, Wright KL. Cannabinoid-induced autophagy regulates
suppressor of cytokine signaling-3 in intestinal epithelium. Am J Physiol
Gastrointest Liver Physiol. 2014 Jul 15;307(2):G140-8. doi:
10.1152/ajpgi.00317.2013. Epub 2014 May 15. PubMed PMID: 24833710; PubMed Central
PMCID: PMC4101681.


9: Kang JJ, Shu L, Park JL, Shayman JA, Bodary PF. Endothelial nitric oxide
synthase uncoupling and microvascular dysfunction in the mesentery of mice
deficient in α-galactosidase A. Am J Physiol Gastrointest Liver Physiol. 2014
Jan;306(2):G140-6. doi: 10.1152/ajpgi.00185.2013. Epub 2013 Nov 14. PubMed PMID:
24232002; PubMed Central PMCID: PMC3920075.


10: Osorio JG, Muzzio FJ. Effects of powder flow properties on capsule filling
weight uniformity. Drug Dev Ind Pharm. 2013 Sep;39(9):1464-75. doi:
10.3109/03639045.2012.728227. PubMed PMID: 23902366.


11: Sreeraman R, Vijayakumar S, Chen AM. Correlation of radiation treatment
interruptions with psychiatric disease and performance status in head and neck
cancer patients. Support Care Cancer. 2013 Dec;21(12):3301-6. doi:
10.1007/s00520-013-1907-3. Epub 2013 Jul 28. PubMed PMID: 23892904.


12: Juárez O, Neehaul Y, Turk E, Chahboun N, DeMicco JM, Hellwig P, Barquera B.
The role of glycine residues 140 and 141 of subunit B in the functional
ubiquinone binding site of the Na+-pumping NADH:quinone oxidoreductase from
Vibrio cholerae. J Biol Chem. 2012 Jul 20;287(30):25678-85. doi:
10.1074/jbc.M112.366088. Epub 2012 May 29. PubMed PMID: 22645140; PubMed Central
PMCID: PMC3408181.


13: Chen AM, Marsano J, Perks J, Farwell G, Luu Q, Donald PJ, Purdy JA.
Comparison of IMRT techniques in the radiotherapeutic management of head and neck
cancer: is tomotherapy "better" than step-and-shoot IMRT? Technol Cancer Res
Treat. 2011 Apr;10(2):171-7. PubMed PMID: 21381795.


14: Métifiot M, Marchand C, Maddali K, Pommier Y. Resistance to integrase
inhibitors. Viruses. 2010 Jun 25;2(7):1347-66. PubMed PMID: 20706558; PubMed
Central PMCID: PMC2920056.


15: Chen A, Lee N, Yang C, Liu T, Narayan S, Vijayakumar S, Purdy J. Comparison
of intensity-modulated radiotherapy using helical tomotherapy and segmental
multileaf collimator-based techniques for nasopharyngeal carcinoma: dosimetric
analysis incorporating quality assurance guidelines from RTOG 0225. Technol
Cancer Res Treat. 2010 Jun;9(3):291-8. PubMed PMID: 20441239.


16: Corn BW, Wang M, Fox S, Michalski J, Purdy J, Simpson J, Kresl J, Curran WJ
Jr, Diaz A, Mehta M, Movsas B. Health related quality of life and cognitive
status in patients with glioblastoma multiforme receiving escalating doses of
conformal three dimensional radiation on RTOG 98-03. J Neurooncol. 2009
Nov;95(2):247-257. doi: 10.1007/s11060-009-9923-3. Epub 2009 Jun 16. PubMed PMID:
19533025; PubMed Central PMCID: PMC2864919.


17: Delelis O, Malet I, Na L, Tchertanov L, Calvez V, Marcelin AG, Subra F,
Deprez E, Mouscadet JF. The G140S mutation in HIV integrases from
raltegravir-resistant patients rescues catalytic defect due to the resistance
Q148H mutation. Nucleic Acids Res. 2009 Mar;37(4):1193-201. doi:
10.1093/nar/gkn1050. Epub 2009 Jan 7. PubMed PMID: 19129221; PubMed Central
PMCID: PMC2651800.


18: Garrison AP, Dekaney CM, von Allmen DC, Lund PK, Henning SJ, Helmrath MA.
Early but not late administration of glucagon-like peptide-2 following ileo-cecal
resection augments putative intestinal stem cell expansion. Am J Physiol
Gastrointest Liver Physiol. 2009 Mar;296(3):G643-50. doi:
10.1152/ajpgi.90588.2008. Epub 2008 Dec 31. PubMed PMID: 19118113; PubMed Central
PMCID: PMC2660180.


19: Stockx EM, Anderson CR, Murphy SM, Cooke IR, Berger PJ. The development of
descending projections from the brainstem to the spinal cord in the fetal sheep.
BMC Neurosci. 2007 Jun 18;8:40. PubMed PMID: 17577416; PubMed Central PMCID:
PMC1919385.


20: Stockx EM, Anderson CR, Murphy SM, Cooke IR, Berger PJ. A map of the major
nuclei of the fetal sheep brainstem. Brain Res Bull. 2007 Jan 9;71(4):355-64.
Epub 2006 Oct 27. PubMed PMID: 17208652.